In vivo Drug Screening to Identify Anti-metastatic Drugs in Twist1a-ER(T2) Transgenic Zebrafish

Here, we present an in vivo drug screening protocol using a zebrafish model of metastasis for the identification of anti-metastatic drugs. A tamoxifen-controllable Twist1a-ER(T2) transgenic zebrafish line was established to serve as a platform for the identification. By crossing Twist1a-ER(T2) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Joji, Makinoshima, Hideki, Gong, Zhiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bio-Protocol 2023
Materias:
Methods Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213071/
https://www.ncbi.nlm.nih.gov/pubmed/37251091
http://dx.doi.org/10.21769/BioProtoc.4673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213071/
https://www.ncbi.nlm.nih.gov/pubmed/37251091
http://dx.doi.org/10.21769/BioProtoc.4673

Ejemplares similares